A girl with fragile X premutation from sperm donation

American Journal of Medical Genetics, Part A

Volumn 146, Issue 7, 2008, Pages 888-892

  Wirojanan, Juthamas ^a,b   Angkustsiri, Kathleen ^a,c   Tassone, Flora ^a,d   Gane, Louise W ^a   Hagerman, Randi J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fragile X syndrome; Genetic screening; Premutation; Sperm donation

Indexed keywords

ALLELE; ARTICLE; ATAXIA; CASE REPORT; DNA SCREENING; EMOTIONAL DEPRIVATION; FEMALE; FRAGILE X SYNDROME; GAMETE; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; LEARNING DISORDER; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; SCHOOL CHILD; SPEECH THERAPY; SPERM DONOR;

CHILD; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MALE; MUTATION; SPERMATOZOA; TISSUE DONORS;

EID: 41849100394     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31876     Document Type: Article

References (40)

1. American Society for Reproductive Medicine. 2004. Appendix A: Minimal genetic screening for gamete donors. Fert Steril 82:S22-23.
2. Arocena DG, Iwahashi CK, Won N, Beilina A, Ludwig AL, Tassone F, Schwartz PH, Hagerman PJ. 2005. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum Mol Genet 14:3661-3671.
3. Aziz M, Stathopulu E, Callias M, Taylor C, Turk J, Oostra B, Willemsen R, Patton M. 2003. Clinical features of boys with fragile X premutations and intermediate alleles. Am J Med Genet Part B Neuropsychiatr Genet 121B:119-127.
4. Beckett L, Yu Q, Long AN. 2005. The impact of fragile X: Prevalence, numbers affected, and economic impact. The National Fragile X awareness day Research Seminar, Sacramento, CA.
5. Berry-Kravis E, Potanos K, Weinberg D, Zhou L, Goetz CG. 2005. Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation. Ann Neurol 57:144-147.
6. Connally AJ. 1997. Key math-revised/NU: A diagnostic inventory of essential mathematics circle pines. MN: American Guidance Services.
7. Conners C. 1997. Conners' rating scales-revised North Tonawanda. NY: Multi-Health Systems.
8. Cornish K, Kogan C, Turk J, Manly T, James N, Mills A, Dalton A. 2005. The emerging fragile X premutation phenotype: Evidence from the domain of social cognition. Brain Cogn 57:53-60.
9. Dombrowski C, Levesque S, Morel ML, Rouillard P, Morgan K, Rousseau F. 2002. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 11:371-378.
10. Dunn LM, Dunn LM. 1997. Peabody picture vocabulary test, 3rd edition. Circle Pines: AGS Publishing.
11. Farzin F, Perry H, Hessl D, Loesch D, Cohen J, Bacalman S, Gane L, Tassone F, Hagerman P, Hagerman R. 2006. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr 27:S137-144.
12. Goodlin-Jones BL, Tassone F, Gane LW, Hagerman RJ. 2004. Autistic spectrum disorder and the fragile X premutation. J Dev Behav Pediatr 25:392-398.
13. Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J, Hessl D, Becker EJ, Papazian J, Leehey MA, Hagerman RJ, Hagerman PJ. 2006. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129:243-255.
14. Hagerman RJ. 2006. Lessons from fragile X regarding neurobiology, autism, and neurodegeneration. J Dev Behav Pediatr 27:63-74.
15. Hagerman PJ, Hagerman RJ. 2004. The fragile-X premutation: A maturing perspective. Am J Hum Genet 74:805-816.
16. Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA, Tassone F, Hessl D, Harris SW, Zhang L, Jardin T, Gane LW, Ferranti J, Ruiz L, Leehey MA, Grigsby J, Hagerman PJ. 2004. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 74:1051-1056.
17. Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, Hagerman PJ, Hagerman RJ. 2005. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet Part B Neuropsychiatr Genet 139B:115-121.
18. Hessl D, Rivera S, Koldewyn K, Cordeiro L, Adams J, Tassone F, Hagerman PJ, Hagerman RJ. 2007. Amygdala dysfunction in men with the fragile X premutation. Brain 130:404-416.
19. Iwahashi CK, Yasui DH, An HJ, Greco CM, Tassone F, Nannen K, Babineau B, Lebrilla CB, Hagerman RJ, Hagerman PJ. 2006. Protein composition of the intranuclear inclusions of FXTAS. Brain 129:256-271.
20. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ. 2004. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291:460-469.
21. Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. 2007. Fragile-X syndrome and fragile-X associated tremor/ataxia syndrome: Two faces of F MR1. Lancet Neurol 6:45-55.
22. Johnston C, Eliez S, Dyer-Friedman J, Hessl D, Glaser B, Blasey C, Taylor A, Reiss A. 2001. Neurobehavioral phenotype in carriers of the fragile X premutation. Am J Med Genet 103:314-319.
23. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, Schopler E. 1989. Autism diagnostic observation schedule: A standardized observation of communicative and social behavior. J Autism Dev Disord 19:185-212.
24. Lord C, Rutter M, Le Couteur A. 1994. Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659-685.
25. Maddalena A, Richards CS, McGinniss MJ, Brothman A, Desnick RJ, Grier RE, Hirsch B, Jacky P, McDowell GA, Popovich B, Watson M, Wolff DJ. 2001. Technical standards and guidelines for fragile X: The first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med 3:200-205.
26. Moore CJ, Daly EM, Schmitz N, Tassone F, Tysoe C, Hagerman RJ, Hagerman PJ, Morris RG, Murphy KC, Murphy DG. 2004. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia 42:1934-1947.
27. Nolin SL, Brown WT, Glicksman A, Houck GE Jr, Gargano AD, Sullivan A, Biancalana V, Brondum-Nielsen K, Hjalgrim H, Holinski-Feder E, Kooy F, Longshore J, Macpherson J, Mandel JL, Matthijs G, Rousseau F, Steinbach P, Vaisanen ML, von Koskull H, Sherman SL. 2003. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72:454-464.
28. Persky S, Reinus JF. 2003. Sertraline hepatotoxicity: A case report and review of the literature on selective serotonin reuptake inhibitor hepatotoxicity. Dig Dis Sci 48:939-944.
29. Reyniers E, Vits L, De Boulle K, Van Roy B, Van Velzen D, de Graaff E, Verkerk AJ, Jorens HZ, Darby JK, Oostra B, Willem PJ. 1993. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat Genet 4:143-146.
30. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos JAG, Schorderet DF, Schaap T, Maccioni L, Russo S, Jacob PA, Schwartz C, Mandel JL. 1994. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe St B12.3: The first 2,253 cases. Am J Hum Genet 55:225-237.
31. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. 1995. Prevalence of carriers of premutation-size alleles of the FMRI gene - And implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57:1006-1018.
32. Sherman SL. 2000. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 97:189-194.
33. Sparrow SS, Cicchetti DV, Balla DA. 2005. Vineland-II adaptive behavior scales. Circle Pines: American Guidance Service.
34. Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL. 2005. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20:402-412.
35. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, Hagerman PJ. 2000. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 91:144-152.
36. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, Eussen BE, van Ommem G-JB, Blonden LAJ, Riggens GJ, Chastain JL, Kunst CB, Galijaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
37. Wechsler D. 2003. Wechsler intelligence scale for children - Fourth Edition (WISC-IV). San Antonio: Harcourt Assessment, Inc.
38. Welt CK, Smith PC, Taylor AE. 2004. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 89:4569-4574.
39. Zeesman S, Zwaigenbaum L, Whelan DT, Hagerman RJ, Tassone E, Taylor SA. 2004. Paternal transmission of fragile X syndrome. Am J Med Genet Part A 129A:184-189.
40. Zuhlke C, Budnik A, Gehlken U, Dalski A, Purmann S, Naumann M, Schmidt M, Burk K, Shwinger E. 2004. FMR1 premutation as a rare cause of late onset ataxia - Evidence for FXTAS in female carriers. J Neurol 251:14 18-1419.